Process and plant for the heat treatment of solids containing titanium

Details for Australian Patent Application No. 2004272735 (hide)

Owner Outotec Oyj

Inventors Beyzavi, Ali-Naghi; Nuber, Dirk; Stockhausen, Werner

Agent Griffith Hack

Pub. Number AU-B-2004272735

PCT Pub. Number WO2005/026397

Priority 103 43 662.6 18.09.03 DE

Filing date 15 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 10 December 2009

International Classifications

C01G 23/00 (2006.01) Compounds of titanium

B01J 8/00 (2006.01) Chemical or physical processes in general, conducted in the presence of fluids and solid particles

B01J 8/18 (2006.01) Chemical or physical processes in general, conducted in the presence of fluids and solid particles - with fluidised particles

B01J 8/38 (2006.01) Chemical or physical processes in general, conducted in the presence of fluids and solid particles

C22B 1/10 (2006.01) Preliminary treatment of ores or scrap

C22B 34/12 (2006.01) Obtaining refractory metals

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026397 Priority application(s): WO2005/026397

26 November 2009 Alteration of Name

  The name of the applicant has been altered to Outotec Oyj 2005 Amendments

10 December 2009 Application Accepted

  Published as AU-B-2004272735

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272737-The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases

2004272731-Plasminogen activators having reduced lysine binding capacity